Papers 4628
1 page of 463 pages (4,628 results)
#1Joy Lee (Monash University)H-Index: 8
#2Tunn Ren Tay (CGH: Changi General Hospital)H-Index: 10
Last. Mark Hew (Monash University)H-Index: 28
view all 7 authors...
BACKGROUND AND OBJECTIVE Inhalational challenge with dry mannitol powder may potentially induce cough by two mechanisms: airway bronchoconstriction or laryngeal irritation. This prospective observational study investigated laryngeal and bronchial components of cough induced by mannitol challenge. METHODS We recruited consecutive patients referred for clinical mannitol challenge. The Newcastle Laryngeal Hypersensitivity Questionnaire (LHQ) was administered. Throughout testing, coughs were audio-r...
#1Raphael Borie (Paris Diderot University)H-Index: 31
#2Elisabetta A. Renzoni (Imperial College London)H-Index: 16
#1Katherine Kearney (UNSW: University of New South Wales)H-Index: 1
#2Joshua Gold (Liverpool Hospital)
Last. Rachael Cordina (USYD: University of Sydney)H-Index: 17
view all 24 authors...
BACKGROUND AND OBJECTIVE Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition occurring in 2%-4% of patients after acute pulmonary embolism. Pulmonary endarterectomy (PEA) is a potential cure for technically operable disease. The epidemiology and long-term outcomes of CTEPH have not been previously described in Australia and New Zealand. METHODS Data were extracted from the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry for patients diagnose...
#1Lisa Lancaster (VUMC: Vanderbilt University Medical Center)H-Index: 17
#2Francesco Bonella (University of Duisburg-Essen)H-Index: 32
Last. Jonathan Langley (Galápagos NV)
view all 7 authors...
BACKGROUND AND OBJECTIVE Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease that requires ongoing care and is associated with considerable socioeconomic burden. We evaluated the IPF care pathway from symptom recognition to treatment. We describe the impact of IPF on healthcare resource use (HCRU), quality of life (QoL) and work impairment, and report differences in patient and physician perspectives using real-world data from France, Germany, Japan and the United States. METHOD...
#1Catherina L. Chang (Waikato Hospital)H-Index: 9
#2Robert J. Hancox (Waikato Hospital)H-Index: 58
Last. Eskandarain Shafuddin (Waikato Hospital)H-Index: 4
view all 5 authors...
#1Alastair Watson (University of Southampton)H-Index: 10
#2Hannah Barnard (University of Birmingham)
Last. Rahul Mukherjee (University of Birmingham)H-Index: 8
view all 6 authors...
#1Robert J. Hancox (University of Otago)H-Index: 58
#2Xian Zhang (University of Otago)
#1Christos Kyriakopoulos (UoI: University of Ioannina)H-Index: 2
#2Georgios Ntritsos (UoI: University of Ioannina)H-Index: 8
Last. Konstantinos Kostikas (UoI: University of Ioannina)H-Index: 46
view all 6 authors...
Tocilizumab has been repurposed against the 'cytokine storm' in the setting of coronavirus disease 2019 (COVID-19). Our aim was to evaluate the efficacy of tocilizumab in the management of hospitalized COVID-19 patients. We searched MEDLINE, CENTRAL and medRxiv for studies of tocilizumab in hospitalized COVID-19 patients. Primary objective was the effectiveness of tocilizumab on mortality. Secondary objectives included the need for invasive mechanical ventilation (IMV), composite endpoints of mo...
#1Grant W. Waterer (UWA: University of Western Australia)H-Index: 52
#2Chiagozie I. Pickens (NU: Northwestern University)H-Index: 2
Last. Richard G. Wunderink (NU: Northwestern University)H-Index: 77
view all 3 authors...
#1Leona Dowman (Monash University)H-Index: 12
#2Anthony K May (Deakin University)H-Index: 1
Last. Anne E Holland (Monash University)H-Index: 61
view all 8 authors...
Top fields of study
Internal medicine
Intensive care medicine
Physical therapy